Entamoeba histolytica: biochemical characterization of a protein disulfide isomerase

Exp Parasitol. 2011 May;128(1):76-81. doi: 10.1016/j.exppara.2011.02.009. Epub 2011 Feb 12.

Abstract

Protein disulfide isomerase (PDI) enzymes are eukaryotic oxidoreductases that catalyze oxidation, reduction and isomerization of disulfide bonds in polypeptide substrates. Here, we report the biochemical characterization of a PDI enzyme from the protozoan parasite Entamoeba histolytica (EhPDI). Our results show that EhPDI behaves mainly as an oxidase/isomerase and can be inhibited by bacitracin, a known PDI inhibitor; moreover, it exhibits chaperone-like activity. Albeit its physiological role in the life style of the parasite (including virulence and survival) remains to be studied, EhPDI could represent a potential drug target for anti-amebic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacitracin / pharmacology
  • Entamoeba histolytica / drug effects
  • Entamoeba histolytica / enzymology*
  • Hydrogen-Ion Concentration
  • Inhibitory Concentration 50
  • Insulin / metabolism
  • Molecular Chaperones / metabolism
  • Muramidase / chemistry
  • Muramidase / metabolism
  • Oxidoreductases / metabolism
  • Protein Disulfide-Isomerases / antagonists & inhibitors
  • Protein Disulfide-Isomerases / chemistry
  • Protein Disulfide-Isomerases / metabolism*
  • Protein Folding
  • Ribonuclease, Pancreatic / chemistry
  • Ribonuclease, Pancreatic / metabolism

Substances

  • Anti-Bacterial Agents
  • Insulin
  • Molecular Chaperones
  • Bacitracin
  • Oxidoreductases
  • Ribonuclease, Pancreatic
  • Muramidase
  • Protein Disulfide-Isomerases